- Trials with a EudraCT protocol (2,078)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
2,078 result(s) found for: Aspartate.
Displaying page 1 of 104.
EudraCT Number: 2007-000436-74 | Sponsor Protocol Number: 432 | Start Date*: 2007-11-27 | |||||||||||
Sponsor Name:Poissy Hospital | |||||||||||||
Full Title: Impact of two glucose control regimens by insulin on hospital mortality in intensive care unit patients (INSUREA Study) | |||||||||||||
Medical condition: hyperglycemia in critical care unit patients | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003817-32 | Sponsor Protocol Number: LOLA-Merz:WMDHP39937 | Start Date*: 2013-01-08 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Brain muscle axis during treatment of hepatic encephalopathy with L-ornithine L-aspartate | |||||||||||||
Medical condition: Hepatic Encephalopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004111-22 | Sponsor Protocol Number: CSOM230B2305 | Start Date*: 2007-01-05 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind study to assess the safety and efficacy of different dose levels of Pasireotide (SOM230) s.c. over a 6 month treatment period in patients with de novo, persistent or recu... | |||||||||||||
Medical condition: Cushing’s disease is rare disease that is caused by an adrenocorticotropic hormone (ACTH) secreting pituitary adenoma. The elevated ACTH secreted by these tumors stimulates the adrenal glands to pr... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) BE (Completed) IT (Completed) FI (Completed) FR (Completed) DE (Completed) PT (Completed) GR (Completed) GB (Completed) HU (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003790-41 | Sponsor Protocol Number: JAN12006-01 | Start Date*: 2015-05-11 |
Sponsor Name:Spherium Biomed | ||
Full Title: Randomised, double-blinded, placebo and active comparator controlled exploratory clinical trial to assess the efficacy and safety of a triple combination of Ibuprofen, magnesium and ascorbic acid ... | ||
Medical condition: Temporomandibular joint dysfunction syndrome. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006841-25 | Sponsor Protocol Number: CRAD001CCH08t | Start Date*: 2009-08-24 | |||||||||||
Sponsor Name:Oncology Institute of Southern Switzerland | |||||||||||||
Full Title: Phase II study of the combination of RAD001 and Letrozole in patients with recurrent endometrial cancer | |||||||||||||
Medical condition: Recurrent endometrial cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001816-56 | Sponsor Protocol Number: HUM 05-064 | Start Date*: 2006-05-11 |
Sponsor Name:Rigshospitalet | ||
Full Title: Can PET scan be used to assess disease activity in patients with sarcoidosis during treatment with adalimumab (Humira)? | ||
Medical condition: sarcoidosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003245-29 | Sponsor Protocol Number: SA652013 | Start Date*: 2016-12-19 |
Sponsor Name:Amsterdam AMC, locatie AMC | ||
Full Title: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy | ||
Medical condition: Prevention of symptomatic gallstone disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005015-17 | Sponsor Protocol Number: GE09-01 | Start Date*: 2009-05-13 |
Sponsor Name:VU university medical centre | ||
Full Title: Effect of N-acetylcysteine on thiopurine related hepatotoxicity in IBD patients | ||
Medical condition: adult patients (18-70 years old) who have been treated with azathioprine, 6-mercaptopure or 6-thioguanine for inflammatory bowel disease, in whom hepatotoxicity occured as an adverse event, are eli... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-005019-28 | Sponsor Protocol Number: P00996 | Start Date*: 2005-05-09 |
Sponsor Name:Papworth Hospital NHS Foundation Trust | ||
Full Title: Diabetes therapy to improve body mass index pulmoanry function in cystic fibrosis subjects with abnormal blood glucose | ||
Medical condition: Cystic fibrosis related diabetes mellitus | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003230-15 | Sponsor Protocol Number: BEV-EFF | Start Date*: 2006-10-17 |
Sponsor Name:University Clinic Internal Medicine I | ||
Full Title: Phase I/II study investigating increasing doses of bevacizumab in patients with malignant effusion | ||
Medical condition: Malignant effusion in cancer patients requiring frequent centesis, at least two within six weeks | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024265-40 | Sponsor Protocol Number: KETA-FAN | Start Date*: 2011-10-27 | |||||||||||
Sponsor Name:HOSPITAL UNIVERSITARI DE BELLVITGE | |||||||||||||
Full Title: Perineural vs systemic N-methyl-D-aspartate (NMDA) receptors antagonism with ketamine as a reverser of peripheral and central sensitization in phantom limb pain | |||||||||||||
Medical condition: Phantom limb pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006295-17 | Sponsor Protocol Number: MedTrace-002 | Start Date*: 2022-04-08 | |||||||||||
Sponsor Name:MedTrace Pharma | |||||||||||||
Full Title: A Phase 3, Multicenter, Open Label Study to Confirm the Diagnostic Potential of Intravenously Administered 15O- H2O to Identify Coronary Artery Disease During Pharmacological Stress and Resting Con... | |||||||||||||
Medical condition: Coronary Artery Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001762-13 | Sponsor Protocol Number: 747-401 | Start Date*: 2018-08-01 |
Sponsor Name:Intercept Pharmaceuticals, Inc. | ||
Full Title: A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients with Primary Biliary Cholangitis and Moderate to Severe Hepa... | ||
Medical condition: Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) BE (Completed) HU (Prematurely Ended) EE (Prematurely Ended) LT (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-004876-23 | Sponsor Protocol Number: M16-133 | Start Date*: 2017-09-13 | |||||||||||
Sponsor Name:AbbVie Deutschland | |||||||||||||
Full Title: A Single Arm, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of Glecaprevir(GLE)/Pibrentasvir(PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotypes 1 – 6 ... | |||||||||||||
Medical condition: Chronic Hepatitis C infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) DE (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004322-24 | Sponsor Protocol Number: ARN-509-003 | Start Date*: 2013-08-27 | |||||||||||
Sponsor Name:Aragon Pharmaceuticals, Inc | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study of ARN-509 in Men with Non-Metastatic (M0) Castration-Resistant Prostate Cancer | |||||||||||||
Medical condition: Castration-Resistant Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: AT (Ongoing) FI (Completed) SE (Completed) NL (Trial now transitioned) BE (Trial now transitioned) IT (Ongoing) NO (Completed) DE (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) DK (Ongoing) HU (Ongoing) CZ (Trial now transitioned) SK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013787-39 | Sponsor Protocol Number: I2I-MC-JMMD | Start Date*: 2009-09-07 | ||||||||||||||||
Sponsor Name:Eli Lilly and company | ||||||||||||||||||
Full Title: A Phase 2 Study to Evaluate LY2603618 in Combination with Pemetrexed in Patients with Advanced or Metastatic Non-small Cell Lung Cancer | ||||||||||||||||||
Medical condition: Advanced or metastatic non-squamous second-line Non-small cell lung cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-008476-14 | Sponsor Protocol Number: CAP001 | Start Date*: 2009-08-07 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | ||
Full Title: A Pharmacokinetic Study of Adjuvant Capecitabine in Patients who have undergone Proximal Pancreatico-Duodenectomy for Resection of Pancreatic Adenocarcinoma | ||
Medical condition: For patients who have undergone proximal pancreatico-duodenectomy for resection of pancreatic adenocarcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005472-13 | Sponsor Protocol Number: Ply-5013 | Start Date*: 2008-09-19 | |||||||||||
Sponsor Name:Plymouth Hospitals NHS Trust | |||||||||||||
Full Title: Phase II Single Agent Lenalidomide (Revlimid) in Relapsed / Refratory Mantle Cell Lymphoma. | |||||||||||||
Medical condition: Relapsed / Refractory Mantle Cell Lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002319-26 | Sponsor Protocol Number: D8830C00002 | Start Date*: 2005-12-20 |
Sponsor Name:AstraZeneca AB | ||
Full Title: Efficacy and safety of AZD9056 200 mg once daily versus placebo in adult patients with active Crohn’s disease – A randomized, double-blind, four week, parallel-group, multicentre, phase II study | ||
Medical condition: Crohn's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) AT (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011525-13 | Sponsor Protocol Number: V001 | Start Date*: 2009-08-28 | |||||||||||
Sponsor Name:Vernalis (R&D) Limited | |||||||||||||
Full Title: Phase II Open-label Pilot Study of V3381, a Novel N-Methyl-D-Aspartate Receptor Antagonist, in Chronic Cough Patients attending a Specialist Clinic | |||||||||||||
Medical condition: Treatment resistant and Idiopathic Chronic Cough | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.